Glucocorticoid-induced Osteoporosis
📧 Sign up to get email alerts when something new happens for Glucocorticoid-induced Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients [Phase 4]
Phase 4 trial update evaluating the effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis pat…
-
FDA approval · 2020-08-06FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Risendronate Sodium from Aurobindo Pharma Limited.
-
FDA approval · 2020-06-08FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
FDA approves a supplemental application for BINOSTO (alendronate sodium) submitted by Radius Health, Inc.
-
FDA approval · 2020-04-06FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories under NDA 021318.
-
FDA approval · 2019-10-03FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Teriparatide submitted by Prasco Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-19FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for alendronate sodium by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2019-07-09FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industires Inc.)
FDA approved Sun Pharmaceutical's risendronate sodium as an original application for a generic product, with indications for osteoporosis-re…
-
FDA approval · 2019-02-15FDA Approved: RISEDRONATE SODIUM — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd)
FDA approved the generic drug risedronate sodium under an Original Application, expanding access to this bisphosphonate for osteoporosis- an…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids [Phase 3]
Phase 3 trial comparing denosumab with risedronate in individuals taking glucocorticoids; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Percutaneous Vertebroplasty Versus Conservative Treatment in GIOPVCF
This clinical trial update compares percutaneous vertebroplasty with conservative treatment for glucocorticoid-induced osteoporosis with ver…
-
FDA approval · 2017-04-28FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories. This action pertains to a supplemental approv…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Alendronate Osteoporosis Study [Phase 2, Phase 3]
This clinical trial update notes completion of phase 2 and phase 3 for alendronate in glucocorticoid-associated osteopenia and osteoporosis.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial evaluating genistein aglycone for glucocorticoid-induced osteoporosis; current status is unknown.
-
FDA approval · 2016-11-29FDA Approved: RISEDRONATE SODIUM — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for a generic rise-dronate sodium product (RISEDRONATE SODIUM). The approved i…
-
FDA approval · 2016-10-21FDA Approved: RISEDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original ANDA for risedronate sodium, a generic osteoporosis treatment, enabling market entry.
-
FDA approval · 2016-07-14FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic zoledronic acid product from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals)…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. [Phase 4]
Phase 4 trial evaluating once-monthly ibandronate (Bonviva) for prevention of glucocorticoid-induced osteoporosis has completed, with result…
-
FDA approval · 2016-03-29FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC. This action indicates regula…
-
FDA approval · 2016-03-22FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
The FDA approved a supplemental application for Binosto (alendronate sodium) from Radius Health, Inc., updating the product labeling as part…
-
FDA approval · 2016-02-12FDA Approved: ALENDRONATE SODIUM — Supplemental Application (EXELAN PHARMACEUTICALS INC.)
FDA approved a supplemental application for alendronate sodium from Exelan Pharmaceuticals Inc. under the ANDA program.
-
FDA approval · 2015-12-15FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for risendronate sodium submitted by Apotex Corp., resulting in an approved change to the marketed p…
-
FDA approval · 2015-12-09FDA Approved: RISEDRONATE SODIUM — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for risendronate sodium (generic risendronate) from Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-11-30FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for FOSAMAX (alendronate sodium) from Organon LLC.
-
FDA approval · 2015-11-30FDA Approved: RISEDRONATE SODIUM — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original ANDA for generic risedronate sodium (RISEDRONATE SODIUM), authorizing its marketing in the United State…
-
FDA approval · 2015-11-30FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' risendronate sodium generic product under an Original Application (ANDA). Risendronate sodiu…